A team of researchers from the Germans Trias i Pujol Research Institute (IGTP) and Institut Català d'Oncologia (ICO) has studied alterations in the KRAS gene in colorectal cancer by combining genomic ...

In about 5–10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients.

Implications for colorectal cancer patients considering immunotherapy Although rare, patients with CRC benefit from identifying the exact type of POLE mutation they might carry. Those with LOP POLE ...

The order of cancer-driving mutations—genetic changes—plays an important role in whether tumors in the intestine can develop, new research reveals. Subscribe to our newsletter for the latest sci-tech ...